Dynamic Transnomic Code for Pharmaceutical Lifecycle Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional code systems for tracking pharmaceuticals and implantable devices are static and limited in the information they can provide throughout the product life cycle, failing to accommodate dynamic and extensible data needs, particularly in tracking the effects of product use.
Innovation Solution
A transnomic code system that includes a prescriber interface, pharmaceutical interface, and management server, allowing for dynamic and extensible data tracking through a unique transnomic code that can be updated and accessed by various stakeholders throughout the product life cycle, including information on product use and health outcomes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of information
If conventional static code systems are used to track products, then the code structure is simple and easy to implement, but the information capacity is limited and cannot track the entire product life cycle
Solution Approach 1:
The patent applies the dynamics principle by transitioning from static bar codes to dynamic RFID tags that can be updated and modified throughout the product life cycle. The RFID system allows information to be changed, added, or deleted at different stages (manufacturing, distribution, use, disposal), enabling continuous tracking and information accumulation without requiring a complete system redesign.
Solution Approach 2:
The patent implements dimensionality change by moving from two-dimensional bar code data storage to multi-dimensional RFID data capacity. The RFID system provides not only product identification but also temporal (time-stamped events), spatial (location tracking), and contextual (usage conditions) dimensions of information, dramatically expanding the information capacity beyond conventional codes.
2Productivity
If conventional bar codes are used, then the system is simple to operate, but it cannot provide real-time updates or track product movement through the supply chain
Solution Approach 1:
The patent applies continuity of useful action by implementing continuous, real-time tracking throughout the entire product life cycle. The RFID system continuously captures and updates information at each stage (manufacturing, distribution, dispensing, use, disposal) without interruption, eliminating the gaps and manual data entry delays inherent in conventional bar code systems.
Solution Approach 2:
The patent replaces the mechanical scanning and manual data entry system of bar codes with automated RFID electromagnetic field-based tracking. This substitution enables wireless, contactless reading of product information at multiple points simultaneously, dramatically improving tracking efficiency and eliminating the time loss associated with sequential scanning and manual updates.
3Adaptability or versatility
If static codes with finite information are used, then the code structure is straightforward, but it cannot accommodate extensible data or track effects of product use
Solution Approach 1:
The patent implements universality by designing the RFID system to perform multiple functions within a single framework: product identification, supply chain tracking, usage monitoring, patient outcome tracking, and disposal verification. The same RFID infrastructure supports diverse data types and tracking requirements across different stages of the product life cycle, making the system highly adaptable and versatile.
Data Source
AI summary
A method and system for tracking goods is provided wherein the system is a transnomic code system. The transnomic code system includes a prescriber interface, a pharmaceutical interface, a pharmacy interface and a management server that communicate via communication mediums, such as an electronic prescribing switch and the Internet. The transnomic code is a dynamic code that includes a tracking code and one or more information sets, wherein each information set includes a read header and extensible content. The transnomic code is assigned to a product, such as a pharmaceutical product. The system allows for adding information sets to the transnomic code at any point during the life-cycle of a product.